SCHEMBL15722716

SCHEMBL15722716

Cn1c2c(c3ccccc31)CC=C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.48
▸ HTR2A P28223 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ MAOA P21397 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ACHE P22303 3/20 0.42
▸ MAPT P10636 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAOB P27338 1/20 0.40
▸ ALKBH5 Q6P6C2 1/20 0.38
▸ FTO Q9C0B1 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ NQO2 P16083 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22298378 0.89 GPR3 (0.45) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL9999764 0.82 ACHE (0.47) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL21913875 0.80 ACHE (0.45) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL4865387 0.78 GPR3 (0.30) GPR3HTR2AHTR2C
SCHEMBL4868842 0.77 MAOA (0.36) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL22044320 0.74 HPGD (0.47) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL21912939 0.73 GPR3 (0.47) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL20824722 0.73 HTR2A (0.43) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL23352286 0.72 GPR3 (0.38) GPR3HTR2AHTR2CMAOAKDM4E
SCHEMBL4870982 0.70 ALDH1A1 (0.44) KDM4EMAPK1CYP1A2HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640252-A1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS UDC Ireland Limited (IE) 2020-04-22 — — EP disclosed
US-9995865-B2 Phase difference plate, circularly polarizing plate, and image display device ZEON CORPORATION (JP) 2018-06-12 — — US disclosed
US-20180143361-A1 CIRCULARLY POLARIZED LIGHT SEPARATING FILM AND METHOD FOR PRODUCING SAME ZEON CORPORATION (JP) 2018-05-24 — — US disclosed
US-20180120487-A1 MULTILAYER FILM MANUFACTURING METHOD AND MULTILAYER FILM ZEON CORPORATION (JP) 2018-05-03 — — US disclosed
US-20180101069-A1 MULTILAYER FILM AND METHOD FOR MANUFACTURING SAME, METHOD FOR MANUFACTURING OPTICALLY ANISOTROPIC TRANSFER BODY, OPTICALLY ANISOTROPIC LAYER, OPTICALLY ANISOTROPIC MEMBER, AND OPTICAL LAYERED BODY ZEON CORPORATION (JP) 2018-04-12 — — US disclosed
US-20180072952-A1 LIQUID CRYSTAL COMPOSITION, METHOD FOR PRODUCING RETARDATION LAYER, AND CIRCULARLY POLARIZING PLATE ZEON CORPORATION (JP) 2018-03-15 — — US disclosed
US-20180039005-A1 TRANSFER BODY FOR OPTICAL FILM, OPTICAL FILM, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND METHOD FOR MANUFACTURING OPTICAL FILM ZEON CORPORATION (JP) 2018-02-08 — — US disclosed
US-20170368793-A1 MULTILAYER FILM, OPTICALLY ANISOTROPIC LAYERED BODY, CIRCULARLY POLARIZING PLATE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND MANUFACTURING METHOD ZEON CORPORATION (JP) 2017-12-28 — — US disclosed
US-20170363790-A1 MULTILAYER FILM, USE THEREOF, AND PRODUCTION METHOD THEREOF ZEON CORPORATION (JP) 2017-12-21 — — US disclosed
US-20170349539-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE ZEON CORPORATION (JP) 2017-12-07 — — US disclosed
US-20160145363-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC MATERIAL ZEON CORPORATION (JP) 2016-05-26 — — US disclosed
US-9207360-B2 Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body ZENO CORPORATION (JP) 2015-12-08 — — US disclosed
US-9207362-B2 Copolymer, optically anisotropic substance, and oriented polymer film ZEON CORPORATION (JP) 2015-12-08 — — US disclosed
US-20150285979-A1 LIQUID CRYSTAL COMPOSITION, PHASE DIFFERENCE PLATE, IMAGE DISPLAY DEVICE, AND METHOD FOR CONTROLLING WAVELENGTH DISPERSION IN OPTICALLY ANISOTROPIC LAYER ZEON CORPORATION (JP) 2015-10-08 — — US disclosed
US-20150277010-A1 PHASE DIFFERENCE PLATE, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE ZEON CORPORATION (JP) 2015-10-01 — — US disclosed
US-20150274647-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE ZEON CORPORATION (JP) 2015-10-01 — — US disclosed
US-20150232625-A1 COPOLYMER, OPTICALLY ANISOTROPIC SUBSTANCE, AND ORIENTED POLYMER FILM ZEON CORPORATION (JP) 2015-08-20 — — US disclosed
US-20150175564-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND ZEON CORPORATION (JP) 2015-06-25 — — US disclosed
US-20140235857-A1 INTERMEDIATE FOR MANUFACTURE OF POLYMERIZABLE COMPOUND AND PROCESS FOR MANUFACTURE THEREOF ZEON CORPORATION (JP) 2014-08-21 — — US disclosed
US-20140142266-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC BODY ZEON CORPORATION (JP) 2014-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235857-A1 INTERMEDIATE FOR MANUFACTURE OF POLYMERIZABLE COMPOUND AND PROCESS FOR MANUFACTURE THEREOF COASY, CYBA, CYP1B1 GPR3 3433/4885HTR2A 1180/4885HTR2C 1397/4885
US-20150274647-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE PYM1, CCNB2, CCNT1 GPR3 3213/4885HTR2A 1381/4885HTR2C 998/4885
US-20150175564-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND PYM1, C5, C1S GPR3 1758/4885HTR2A 1220/4885HTR2C 940/4885
US-20160145363-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC MATERIAL F12, C1S, C5 GPR3 2137/4885HTR2A 1357/4885HTR2C 1124/4885
US-20170349539-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE PYM1, CCNB2, CCNT1 GPR3 3213/4885HTR2A 1381/4885HTR2C 998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback